BDSX Q4 2021 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

Q4 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$7M-73.3% YoY

Gross Profit

$5M65.5% margin

Operating Income

-$12M-161.7% margin

Net Income

-$13M-183.9% margin

EPS (Diluted)

$-0.49

QoQ Revenue Growth

+10.6%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$11M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$76M

Total Liabilities

$56M

Stockholders' Equity

$20M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$27M	-73.3%
Gross Profit	$5M	$12M	-61.8%
Operating Income	-$12M	-$3M	-340.2%
Net Income	-$13M	-$5M	-193.0%

Revenue Segments

Diagnostic Tests

$6M81%

Service

$1M19%